Timur Köse Selected Research

Timur Köse Research Topics

Disease

11	Chronic Periodontitis 01/2020 - 11/2005
10	Aggressive Periodontitis (Periodontosis) 11/2020 - 04/2006
5	Periodontitis 01/2020 - 04/2007
4	Periodontal Diseases (Periodontal Disease) 04/2021 - 08/2006
3	Infections 01/2020 - 08/2005
2	Inflammation (Inflammations) 02/2022 - 11/2020
2	Neoplasms (Cancer) 02/2022 - 11/2016
2	Hypoxia (Hypoxemia) 11/2020 - 01/2019
2	Gingivitis 01/2019 - 01/2018
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2022
1	Cardiotoxicity 02/2022
1	Hypercholesterolemia 02/2022
1	Pneumonia (Pneumonitis) 01/2020
1	Diabetes Mellitus 10/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2019
1	Hypertension (High Blood Pressure) 10/2019
1	Necrosis 01/2019
1	Panic Disorder (Panic Attack) 12/2018
1	Vascular System Injuries 08/2018
1	Abscess 08/2018
1	Persistent Infection 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Lung Neoplasms (Lung Cancer) 11/2016
1	Migraine with Aura (Familial Hemiplegic Migraine) 10/2016
1	Headache (Headaches) 10/2016
1	Vertigo (Positional Vertigo) 10/2016
1	Migraine Disorders (Migraine) 10/2016
1	Type 2 Episodic Ataxia 10/2016
1	Acromegaly 08/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2015
1	Xerostomia 06/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2008
1	Hemorrhage 09/2006

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 02/2022 - 10/2016
3	DNA (Deoxyribonucleic Acid)IBA 09/2006 - 04/2006
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 01/2019
2	collagen type I trimeric cross-linked peptideIBA 01/2020 - 06/2011
2	Collagen Type I (Type I Collagen)IBA 01/2020 - 06/2011
2	OsteocalcinIBA 01/2020 - 06/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2005
2	InterleukinsIBA 01/2019 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 08/2014 - 12/2007
2	AngiotensinogenIBA 04/2009 - 03/2009
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2009 - 03/2009
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2008 - 12/2007
2	Plasminogen Activators (Plasminogen Activator)IBA 07/2007 - 04/2007
2	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2007 - 04/2007
2	Plasminogen Activator Inhibitor 1IBA 07/2007 - 04/2007
1	Clomiphene (Clomifene)FDA LinkGeneric 03/2022
1	Tamoxifen FDA LinkGeneric 03/2022
1	glutaryl-coenzyme A (glutaryl-CoA)IBA 02/2022
1	Cytostatic AgentsIBA 02/2022
1	Caspase 3 (Caspase-3)IBA 02/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2022
1	Fluvastatin FDA Link 02/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2022
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2022
1	CholesterolIBA 02/2022
1	NF-kappa B (NF-kB)IBA 02/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022
1	Messenger RNA (mRNA)IBA 02/2022
1	Proteins (Proteins, Gene)FDA Link 02/2022
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 04/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 10/2019
1	Losartan (Cozaar)FDA LinkGeneric 10/2019
1	BilirubinIBA 08/2018
1	CytokinesIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2018
1	ApelinIBA 11/2016
1	Acetazolamide (Diamox)FDA LinkGeneric 10/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2015
1	Fibrinogen (Factor I)FDA Link 08/2015
1	EnzymesIBA 08/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 04/2015
1	Tissue Inhibitor of Metalloproteinase-1IBA 08/2014
1	pyridinolineIBA 06/2011
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 03/2010
1	Type 1 Angiotensin ReceptorIBA 04/2009
1	Angiotensin IIIBA 03/2009
1	AngiotensinsIBA 03/2009
1	ReninIBA 03/2009
1	xialineIBA 06/2008
1	Insulin Glargine (Lantus)FDA Link 03/2008
1	Toll-Like Receptor 2IBA 10/2007
1	Plasminogen InactivatorsIBA 07/2007
1	Tuberculin (PPD)IBA 09/2006
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2006
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2006

Therapy/Procedure

6	Therapeutics 11/2020 - 11/2005
2	Drug Therapy (Chemotherapy) 02/2022 - 11/2016
2	Debridement 01/2020 - 11/2005
1	Glycemic Control 03/2008
1	Oral Hygiene (Dental Hygiene) 01/2008
1	Kidney Transplantation 01/2008